Proteins constitute some of the key players in signaling networks, and most proteins have recognizable, conserved domains that can impart various catalytic functions, such as kinase or guanosine triphosphatase (GTPase) activity; modulate the activity of a catalytic domain; or confer the ability, directly or indirectly, to interact with signaling molecules or other proteins. Structural analyses of protein domains (in isolation or in complex with molecules and peptides), fulllength proteins, or multiprotein complexes can all provide insight into how information is transmitted through signaling networks.
Structural studies have been applied to ion channels, intracellular signaling enzymes, and transcriptional regulators. Structural analysis has provided insight into the mechanisms controlling both voltagegated and ligand-gated channels. The inositol trisphosphate (IP 3 ) receptor, a ligandgated calcium channel associated with the endoplasmic reticulum is a critical component of intracellular calcium signaling pathways and is responsible for the release of signal-dependent release of calcium from intracellular stores. In a Perspective in this series, Hamada and Mikoshiba discuss how IP 3 binding to the N terminus of the receptor causes allosteric conformational changes that mediate gating and activation of the ligand-gated channel. In Reviews in the Archives, Halling et al. and Armstrong describe how structural studies have informed the regulation of voltage-gated calcium channels by calmodulin or voltage-gated potassium channels, respectively.
The guanine nucleotide-binding proteins (G proteins) represent a large complex family of heterotrimeric proteins that regulate many aspects of physiology. These are composed of an α subunit that binds and hydrolyzes guanine nucleotides and the dimeric βγ subunit that contributes to downstream effector signaling, maintaining the system in an inactive state when bound to the α subunit and targeting of the complexes to specific subcellular compartments. A Review in this issue by Dohlman et al. discusses how the helical domain of the α subunit of guanine nucleotide-binding proteins (G proteins) may function both during activation and as a stabilizer of interactions with other proteins. Unlike its mammalian counterparts, the G protein α subunit in Arabidopsis thaliana (AtGPA1) does not require a G protein-coupled receptor for activation and can self-activate. The Research Article in the Archives by Jones et al. shows that this ability is due to the helical domain that is homologous to the one highlighted by Dohlman et al. Substitution of the helical domain of AtGPA1 into an animal G protein α subunit conferred self-activation. A Review in the Archives by Prei ninger and Hamm (complete with animation) highlights mechanisms that regulate the G protein cycle from GTP exchange, signaling, and GTP hydrolysis. Also in the Archives, a Perspective by Ross describes the structural basis for the reciprocal regulation between phospholipase C-β3 (PLC-β3) and its activator, Gα q , for which it acts as a GTPaseactivating protein, thus attenuating its activity. This circuit may enable PLC-β3 to continually monitor the activation state of G q -coupled receptors and facilitate signal transduction. One extensively studied effector of many G proteins is protein kinase A, which exists in an inactive state as a holoenzyme consisting of two catalytic subunits and two regulatory subunits. Binding of adenosine 3′-5′-monophosphate (cAMP), the production of which is regulated by Gα s and Gα i proteins, to the regulatory subunits causes their dissociation from the catalytic subunits, alleviating their inhibition. The Perspective by Elkins and Knapp in this series describes the conformational changes that occur in the PKA holoenzyme upon cAMP binding. Thus, structural studies have revealed insight into regulation of G protein activity and the mechanisms by which the activity of G proteins directs intracellular signaling.
Our understanding of how transcriptional regulators are regulated has also benefited from structural studies. The activity of transcriptional regulators can be controlled by various processes, including changes in conformation induced by stimuli, such as light, interaction with other biomolecules, or changes in cellular localization.VIVID is a cytoplasmic blue-light photoreceptor in the filamentous fungus Neurospora crassa, and the Research Article by Vaidya et al. identifies the structural changes that occur when VIVID dimerizes in the presence of light, thus promoting its ability to interact with another transcription factor and repress this partner's activity. The glucocorticoid receptor transcriptionally activates gene expression in response to ligand binding. The Perspective by Gronemeyer and Bourguet discusses how cocrystallization of the DNA binding domain of the glucocorticoid receptor with various glucocorticoid receptor-binding DNA sequences indicated that the DNA sequence can not only dictate the conformation of the glucocorticoid receptor, but also determine the assembly of distinct regulatory components. The MRTF (myocardin-related transcription factor) group of transcriptional coactivators are localized to the cytoplasm or to the nucleus (where they transcriptionally activate target genes), depending on the availability of monomeric actin. In their Research Article, Mouilleron et al. found that all five actin-binding sites in the actin-binding domain of MRTF-A were required to maintain the cytoplasmic localization of MRTF-A in unstimulated cells. Thus, increasing the concentration of monomeric actin leads to more molecules of actin binding to each molecule of MRTF-A and causes the retention of MRTF-A in the cytoplasm, preventing it from activating target genes.
The interactions of proteins or other molecules is typically mediated by conserved protein domains and structural anal- Various articles in the Archives describe how structural analyses can reveal how protein functions are conserved, or how structural information from homologs can be used to infer conserved mechanisms. In a Perspective, Lamb et al. discuss how the structure of Gal80p, a transcriptional repressor of galactose-metabolizing enzymes, in complex with a peptide from a transcriptional activator revealed the presence of nicotinamide adenine dinucleotide phosphate (NADP). They suggest that Gal80p and a human redox sensor protein that functions in nitric oxide signaling may couple fluctuations in the ratio of NADP to NADPH (the reduced form of NADP + ) to transcriptional changes, thus linking different signaling pathways.
S t r u c t u r a l B i o l o g y
Another Perspective focuses on the kinase ataxia-telangiectasia mutated (ATM), which functions in cell cycle checkpoints and DNA double-strand break repair. Mutations in the gene encoding this kinase are associated with the disease ataxia-telangiectasia. Perry and Tainer discuss how ATM can be directly activated by oxidation, an effect that can explain some of the pathologies seen in ataxia-telangiectasia, and use the structural information available for related kinases to propose the conformation and assembly mechanisms by which oxidative stress modulates ATM activity. emerged with the evolutionary appearance of the animal nervous system. LKB1 is another unusual kinase: It must bind to the pseudokinase STRAD (Ste20-related adaptor) and the scaffolding protein MO25 (mouse protein 25) to be activated. The Perspective by Rajakulendran and Sicheri discusses how activated STRAD adopts a conformation reminiscent of an active kinase, which in turn stabilizes the active conformation of LKB1, suggesting that the relationship between LKB1 and STRAD may have evolved from a substrate-kinase relationship. The Research Article by Ye et al. provides the crystal structure of the catalytic domain of the α-kinase myosin II heavy chain kinase A from Dictyostelium bound to various nucleotides, and identifies features of the active site of α-kinases that differ from those of conventional kinases. Divergence of regulatory mechanisms is not limited to kinases, as discussed in the Perspective by Rittinger. Structural analysis of the conformational changes that occur during the guanosine triphosphatase (GTPase) cycle of Rho family GTPases that are regulated by the guanine nucleotide exchange factor (GEF) DOCK showed that this family of GEFs executes its function in a manner distinct from other GEFs.
Molecular details of how signaling proteins, especially receptors, perform their biological functions can be revealed through structural studies. In Reviews in the Archives, Mizwicki and Norman describe how different vitamin D conformation may elicit distinct signaling outcomes through the vitamin D receptor and Joshi-Saha et al. describe how structural analysis has revealed the mechanism by which the plant hormone abscisic acid activates its receptors to stimulate responses such as closure of plant respiratory pores called stomata. Recognition of microbial nucleic acids, lipids, and proteins by Toll-like receptors (TLRs) stimulate signaling pathways that lead to the transcriptional activation of genes involved in immune and inflammatory responses. The Perspective in the Archives by Lu and Sun focuses on TLR5, which recognizes flagellin, a component of the bacterial flagellum. The crystal structure of the extracellular domain of TLR5 in complex with flagellin revealed that, like other TLRs, TLR5 dimerizes upon ligand binding. However, the ligand-binding mode for TLR5 is distinct from that of previously characterized TLRs. In a Review in this issue, Ferrao et al. describe the intracellular signalosomes that assemble after ligation of TLRs or the interleukin-1 (IL-1) receptor (IL-1R), the domain interactions that enable signalosome formation, and how signalosomes induce the activation of kinases and E3 ubiquitin ligases that result in transcriptional responses to infection.
Structural approaches can also reveal how the mutated forms of signaling molecules contribute to various diseases or can guide the development of drugs. In a Review in the Archives, Vadas et al.describe how the phosphoinositide 3-kinases are regulated by their binding partners and how molecular understanding of these interactions may be exploited for therapeutic benefit. The Perspective in the Archives by Weiss focuses on the leucine-rich repeat kinase 2 (LRRK2); mutations that increase its activity are associated with Parkinson's disease. The structure of the GTPase domain of LRRK2 indicates that it mediates the homodimerization of the protein, thus inhibiting its kinase activity. This may explain the basis for some Parkinson's disease-associated mutations that located outside of the kinase domain.
Research Articles in the Archives by Mukai et al., which describes how structural differences in the interaction of tumor necrosis factor to its two receptors may aid in the development of receptor-specific therapeutics, and by Veldkamp et al., which describes how structural studies of a chemokine and its receptor led to the discovery of an inhibitor of leukocyte chemotaxis, illustrate the potential power of structural studies in aiding drug design. Structural studies can also provide mechanistic information about how drugs that interact with signaling proteins affect their targets. For example, the Research Article in this series by Lin et al. (see also the Perspective by Humphrey and James), describes how some inhibitors of the kinase Akt influence this kinase's accessibility to phosphatases, as well as competitively inhibiting ATP binding. The sphingosine 1-phosphate (S1P) receptor 1 (S1P 1 ) promotes inflammation and has emerged as a drug target for multiple sclerosis. In a Perspective in this series, Parrill et al. discuss how structural analysis of S1P 1 suggests that ligands may laterally diffuse in the plasma membrane to gain access to the binding pocket. Furthermore, identification of the key interactions associated with the binding of S1P and agonists may be helpful in developing drugs that specifically target S1P 1 . Similarly, the mitogen-activated protein kinase (MAPK) p38α enhances inflammation in various diseases; unfortunately, drugs designed to decrease the activity of this kinase tend to have side effects because they target a site in p38α that is conserved in other kinases. Inactivation of p38α is mediated by dephosphorylation by the MAPK phosphatase 5 (MPK5). The crystal structure of the p38α-binding domain of MKP5 with p38α by Zhang et al. (see also the Perspective by Goldsmith) shows that the docking of these two proteins is distinct from that for other MAPKs and their phosphatases. Thus, the unconventional interaction between p38α and MKP5 could lead to the development of antiinflammatory drugs specific for p38α.
Each of the highlighted articles demonstrates the power of structural biology for revealing molecular details regarding signaling proteins. These studies can not only advance our understanding of basic concepts in biochemistry and cell biology, but also provide useful insights that can be leveraged to understand disease and develop new therapeutic strategies.
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